A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the activity of amivantamab in gastric cancer
(GC) and esophageal cancer (EC) participants (Phase 2a), and to characterize the preliminary
antitumor activity of amivantamab in selected GC and EC population (Phase 2b).